Fifth Lane Capital »

Theseus Pharmaceuticals shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Theseus Pharmaceuticals shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Theseus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Theseus Pharmaceuticals held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theseus Pharmaceuticals by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $101k 25k 4.05

More positions owned by Fifth Lane Capital

stock
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dish Network Corporation Cl A
ImmunoGen
Home Depot (HD)
Rpt Realty Sh Ben Int
Iron Horse Acquisitions Corp Unit 10/15/2028 (IROHU)
Mirati Therapeutics
Brookfield Renewable Partner Partnership Unit (BEP)
Evergy (EVRG)
Flex Ord (FLEX)
Chevron Corporation (CVX)
Wec Energy Group (WEC)
Seritage Growth Pptys Cl A (SRG)
Gracell Biotechnologies Sponsored Ads

View all positions for Fifth Lane Capital

Top funds holding Theseus Pharmaceuticals

OrbiMed Advisors
Tang Capital Management
Frazier Life Sciences Management
Vanguard Group
Omega Fund Management
Lynx1 Capital Management
Highbridge Capital Management
Beryl Capital Management
MMCAP International Inc. SPC
ADAR1 Capital Management
Laurion Capital Management
Citadel Advisors
Charles Schwab Investment Management
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Dimensional Fund Advisors

View all funds holding Theseus Pharmaceuticals